Abstract
Streptococcus pneumoniae is one of the most important aetiological agents of bacterial pneumonia and meningitis in the world. This bacterium can cause severe inflammation of lung tissue and disseminate to the central nervous system. Although B cell activation and antibody secretion is considered one of the most important events in the prevention or clearance of bacterial infection by the host, dendritic cells (DCs) and T cells play a fundamental role in the generation of the protective immunity required to prevent the pathogenesis caused by S. pneumoniae infection. Here we review recent studies that have evaluated the impact of DCs and T cells on S. pneumoniae infection and the gene elements encoding virulence factors used by this bacterium to interfere with the appropriate function of these immune cells. This knowledge could be relevant for generating new prophylactic and therapeutic tools and to prevent the severe infection caused by this pathogen.
Keywords: Streptococcus pneumoniae, virulence factors, dendritic cells, T cells, adaptive immunity, adaptive immunity, bacterium, aetiological agents, prophylactic and therapeutic tools
Current Gene Therapy
Title:Gene Elements that Regulate Streptococcus pneumoniae Virulence and Immunity Evasion
Volume: 13 Issue: 1
Author(s): Pamela A. Nieto, Sebastián A. Riquelme, Claudia A. Riedel, Alexis M. Kalergis and Susan M. Bueno
Affiliation:
Keywords: Streptococcus pneumoniae, virulence factors, dendritic cells, T cells, adaptive immunity, adaptive immunity, bacterium, aetiological agents, prophylactic and therapeutic tools
Abstract: Streptococcus pneumoniae is one of the most important aetiological agents of bacterial pneumonia and meningitis in the world. This bacterium can cause severe inflammation of lung tissue and disseminate to the central nervous system. Although B cell activation and antibody secretion is considered one of the most important events in the prevention or clearance of bacterial infection by the host, dendritic cells (DCs) and T cells play a fundamental role in the generation of the protective immunity required to prevent the pathogenesis caused by S. pneumoniae infection. Here we review recent studies that have evaluated the impact of DCs and T cells on S. pneumoniae infection and the gene elements encoding virulence factors used by this bacterium to interfere with the appropriate function of these immune cells. This knowledge could be relevant for generating new prophylactic and therapeutic tools and to prevent the severe infection caused by this pathogen.
Export Options
About this article
Cite this article as:
A. Nieto Pamela, A. Riquelme Sebastián, A. Riedel Claudia, M. Kalergis Alexis and M. Bueno Susan, Gene Elements that Regulate Streptococcus pneumoniae Virulence and Immunity Evasion, Current Gene Therapy 2013; 13 (1) . https://dx.doi.org/10.2174/1566523211313010006
DOI https://dx.doi.org/10.2174/1566523211313010006 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Granulomatous Lung Disease. Disease for Pulmomologists: Diagnosis and Treatment
Current Respiratory Medicine Reviews Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia
Current Medicinal Chemistry Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Current Medicinal Chemistry The Physicochemical and Pharmacokinetic Relationships of Barbiturates – From the Past to the Future
Current Pharmaceutical Design Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design Autoantibody Reaction to Myelin Basic Protein by Plasma Parvovirus B19 IgG in MS Patients
Protein & Peptide Letters Hepatic Manifestations in Juvenile Systemic Lupus Erythematosus
Recent Patents on Inflammation & Allergy Drug Discovery Myeloperoxidase: The Good, the Bad, and the Ugly
Current Immunology Reviews (Discontinued) Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Systematic Review
Current Pediatric Reviews Treatment of Viral Encephalitis
Central Nervous System Agents in Medicinal Chemistry Paeonol, a Powerful Natural Product with Broad Biological Spectra by Inhibiting Inflammatory Pathway
Current Traditional Medicine Ebola Virus Altered Innate and Adaptive Immune Response Signalling Pathways: Implications for Novel Therapeutic Approaches
Infectious Disorders - Drug Targets Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients
Current Neurovascular Research Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
Current Drug Discovery Technologies Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]
CNS & Neurological Disorders - Drug Targets Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
Current Drug Targets